In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Procyon gains additional patent protection for cancer screening test
Techniclone issued patent on tumour necrosis therapy technology
Prima receives Australian Patent for Methods of Treating Cancer with Antibodies
Mitotix announces three U.S. Patents on p16 tumour suppressor gene
Techniclone issued patent extending vascular targeting agent portfolio
Myriad Genetics awarded US patent
Myriad Genetics awarded U.S. patent
SciClone receives patent for treatment of hepatitis B
Nexell Therapeutics initiates program to develop tumour cell test
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
